Your instant 4 share healthcare portfolio

Building a portfolio around these four healthcare stocks could prove highly rewarding for investors

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A healthcare focussed portfolio appears to be one of the most attractive ways to identify and hold companies with strong current earnings and the ability to grow profits over decades, rather than years.

However, if you wanted to build a portfolio of stocks in the healthcare sector which stocks would fit the bill? To approach this question, I have selected four companies, with large stable businesses on one end of the scale and smaller more growth-focussed options at the other.

The large caps

Cochlear Limited (ASX: COH) is an Australian success story with global earnings power. The company is one of a small number of firms with a meaningful share of the implantable hearing device market.

The company recently announced a surprise profit upgrade, with the factors underpinning that upgrade set to continue. Increased healthcare spending by emerging market customers, coupled with brand loyalty from developed markets should see Cochlear prosper for years to come.

CSL Limited (ASX: CSL) is another home grown success story, with CSL originally an acronym for the government-owned Commonwealth Serum Laboratories.

CSL is a global producer of blood products for use in hospitals, as well as vaccines. For patients suffering from haemophilia or liver deficiencies, CSL products are indispensible. If it can build its flu vaccine business into a global player by using the high value medical manufacturing knowledge it has amassed, it could have two huge profit engines driving profit growth for years.

The small caps

Lifehealthcare Group Ltd (ASX: LHC) is a small cap stock that is relatively new to the ASX. The company is a speciality importer of high value implantable medical devices used in complex surgeries, as well as medical hardware like portable ultrasound machines.

The falling Australian dollar, a Federal government review into medical device reimbursements and higher-than-expected interest costs on debt used to fuel acquisitions smashed the share price recently. However, the business has a level of sticky revenue as surgeons who use Lifehealthcare products are relatively loyal as they grow comfortable with the products. Average revenue per surgeon is $447,000, and the company has consistently grown the number of active surgeons by 5% or more a year.

CogState Limited (ASX: CGS) is best defined as a micro cap, and should only be considered by investors with a high risk tolerance. However, the company has the potential to be much much larger based on its impressive results to date.

The company counts over 60% of the largest multi-billion dollar pharmaceutical companies as clients. CogState is in the business of providing scientifically verified cognitive ability testing and measurement services. These tests can be used to test the efficacy of a new drug during trial phases, or to pre-qualify patients for trials. Both processes save pharmaceutical companies substantial costs, meaning CogState has a strong basis for recurring revenue and upselling its services.

Foolish takeaway

Healthcare companies have many of the qualities that make for great long-term investments, and building a portfolio around strong healthcare stocks with competitive advantages or options to grow substantially in the coming years can be a winning strategy.

Motley Fool contributor Ry Padarath has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »